Neuland Laboratories Limited, a global active pharmaceutical ingredient (API) manufacturing and development organization, announced the appointment of Ashutosh Kumar Sinha as Chief Quality Officer of the company, with effect from March 6, 2024.
According to the company’s exchange filing, “Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform you that Mr. Ashutosh Kumar Sinha has been appointed as Chief Quality Officer w.e.f. March 6, 2024.”
Sinha holds M.Sc. in Pharmaceutical Chemistry from Institute of Chemists, Kolkata and is an MBA in Total Quality Management (TQM), from Sikkim Manipal University. He brings over 28 years of experience in the Quality function, working across organizations such as Ranbaxy Labs Ltd, Glenmark Pharma Lab, Dr Reddys Lab and Symbiotec Pharmalab. Prior to joining us he was associated with Syngene International Ltd. as Associate Vice President & Quality Head (Small molecule & Client dedicated centre).
